- Home
- RCEL vs TEI Comparison
RCEL vs TEI Comparison
Compare RCEL & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- TEI
- Stock Information
- Founded
- RCEL N/A
- TEI 1993
- Country
- RCEL United States
- TEI United States
- Employees
- RCEL N/A
- TEI N/A
- Industry
- RCEL Medical/Dental Instruments
- TEI Finance Companies
- Sector
- RCEL Health Care
- TEI Finance
- Exchange
- RCEL Nasdaq
- TEI Nasdaq
- Market Cap
- RCEL 227.5M
- TEI 256.5M
- IPO Year
- RCEL N/A
- TEI N/A
- Fundamental
- Price
- RCEL $9.21
- TEI $5.13
- Analyst Decision
- RCEL Strong Buy
- TEI
- Analyst Count
- RCEL 4
- TEI 0
- Target Price
- RCEL $17.25
- TEI N/A
- AVG Volume (30 Days)
- RCEL 201.7K
- TEI 142.4K
- Earning Date
- RCEL 05-08-2025
- TEI 01-01-0001
- Dividend Yield
- RCEL N/A
- TEI 10.51%
- EPS Growth
- RCEL N/A
- TEI N/A
- EPS
- RCEL N/A
- TEI N/A
- Revenue
- RCEL $64,251,000.00
- TEI N/A
- Revenue This Year
- RCEL $62.33
- TEI N/A
- Revenue Next Year
- RCEL $30.59
- TEI N/A
- P/E Ratio
- RCEL N/A
- TEI N/A
- Revenue Growth
- RCEL 28.14
- TEI N/A
- 52 Week Low
- RCEL $6.90
- TEI $4.35
- 52 Week High
- RCEL $14.16
- TEI $5.39
- Technical
- Relative Strength Index (RSI)
- RCEL 56.76
- TEI 44.18
- Support Level
- RCEL $8.15
- TEI $4.78
- Resistance Level
- RCEL $9.36
- TEI $5.20
- Average True Range (ATR)
- RCEL 0.67
- TEI 0.13
- MACD
- RCEL 0.15
- TEI -0.01
- Stochastic Oscillator
- RCEL 93.90
- TEI 50.72
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments and Money Market Funds.